About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Newer P2 Y12 Inhibitors in ACS: Losing Ground Due to Bleeding
By
Complex Coronary Valvular and Vascular Cases Conference
FEATURING
Sunil Rao
By
Complex Coronary Valvular and Vascular Cases Conference
FEATURING
Sunil Rao
538 views
July 29, 2018
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
14:00
ACC 2024 Insights
ACC 2024 Insights: De-Escalation After ACS - Which Patient, When and…
Feat.
F. Franchi
15:40
ACC 2022 Conference Coverage
ACC 2022: Triple Therapy - When to Use and How Long
Feat.
D. Kumbhani
28:11
Top Ten Topics in Clinical Cardiology 2021
Time to Retire Aspirin?
Feat.
R. Mehran
11:26
Houston Methodist DeBakey Heart and Vascular Center
Aspirin for the Primary Prevention of Cardiovascular Disease: What C…
Feat.
M. Miedema
21:51
Cedars Sinai
Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…
Feat.
W. Boden
07:10
American College of Cardiology
Ticagrelor with or without Aspirin in ACS after PCI (TICO)
Feat.
P. Block,
Y. Jang
11:07
Houston Methodist DeBakey Heart and Vascular Center
Aspirin & Primary Prevention: What Do the Guidelines Say?
Feat.
M. Gulati
17:49
CHEST 2022 Coverage
Perioperative Management of Antithrombotic Therapy
Feat.
J. Douketis
09:14
American College of Cardiology
MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High…
Feat.
V. Fuster,
D. Itchhaporia,
M. Mack,
C. Albert,
J. Grapsa
20:06
Canadian Collaborative Research Network
Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?
Feat.
M. Sabatine
14:20
ARCH Advanced Revascularization Symposium
Highlights and Critiques of ACC/AHA/SCAI Revascularization Guidelines
Feat.
D. A. Cox
12:46
AHA 2022 Conference Coverage
AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…
Feat.
F. Bakaeen
57:14
Northwestern Medicine Cardiovascular Care
Stress Testing in the Real World
Feat.
M. Eimer
25:26
The Texas Heart Institute
The Use of Coronary Artery Calcium Score to Determine Benefit of Asp…
Feat.
E. Hernandez
15:13
Cardiometabolic Health Congress (CMHC)
Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…
Feat.
D. Bhatt
37:35
Top Ten Topics in Clinical Cardiology 2022
Top 10 Coronary Interventional Trials of 2022
Feat.
S. Sharma
16:34
AHA 2022 Conference Coverage
AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…
Feat.
G. W. Stone
12:53
Scottsdale Interventional Forum 2018
What is the Optimal DAPT Duration?
Feat.
R. Yeh
13:36
Houston Methodist DeBakey Heart and Vascular Center
Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy
Feat.
J. Ferreiro
08:07
Houston Methodist DeBakey Heart and Vascular Center
Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Nea…
Feat.
N. Kleiman
